Skip to main content

Table 1 Summary guidance for antifungal dosing in different critically ill patient subpopulations

From: Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy

 

ARC

AKI

RRT

ALF

Amphotericin

Unchanged

Unchanged

Unchanged

Unchanged

Fluconazole

Increase

Decrease

Increase

? Unchanged

Voriconazole

TDM

TDM

TDM

TDM

Itraconazole

TDM

TDM

TDM

TDM

Posaconazole

TDM

TDM

TDM

TDM

Caspofungin

Unchanged

Unchanged

Unchanged

Decrease

Micafungin

Unchanged

Unchanged

Unchanged

Unchanged

Anidulafungin

Unchanged

Unchanged

Unchanged

Unchanged

Flucytosine

TDM

TDM

TDM

TDM

  1. AKI acute kidney injury, ALF acute liver failure, ARC augmented renal clearance, RRT renal replacement therapy, TDM therapeutic drug monitoring